Patients with rheumatoid arthritis were found to have essentially normal granulocyte production, with peak levels in the blood at 7 to 9 days. If the granulocytes in the effusions were indeed sequestered and adynamic, one would expect little labeling of cells in the effusion during the "pulse" of enzyme-rich cells in blood. In the studies, however, blood and synovial effusion leukocytes were sampled simultaneously after methotrexate injection and similar levels of enzyme were found in cells from each source. This indicated that the cells in the effusions were far These observations demonstrated that the turnover of cells in rheunmatoid synovial effusions was quite rapid, probably within a matter of a day or two. To more accurately define the rate of destruction of cells in the effusions, a method of labeling cells within the effusion was needed. This paper presents the results of tagging the cells in rheumatoid effusions with isotopically labeled diisopropylfluorophosphate (DFP). To determine whether the rapid turnover of granulocytes in synovial effusions of rheumatoid arthritis is unique to that disease, observations were made on a 290 Volume 39, April, 1967 Granulocytes in joint diseases HOLLINGSWORTH, SIEGEL, CREASEY smaller number of patients with other, more acute, synovial inflammatory diseases.
PATIENTS AND METHODS

Patients
Twelve experiments in nine patients with rheumatoid arthritis were performed. All patients had chronic arthritis with the effusions present for months or years. To compare with this group, three patients with acute gout, two with Reiter's syndrome, and one with the arthritis of ulcerative colitis were studied. Certain clinical features of the patients and of their synovial effusions are recorded in Table 1 .
Standard clinical criteria (American Rheumatism Association) for the diagnosis of rheumatoid arthritis were employed, and all patients had advanced disease at the time of study. Serum rheumatoid factor was tested by the hospital laboratory, using both the sensitized sheep cell and latex tests. The patients with gout had hyperuricemia and characteristic needle-like urate crystals in the synovial exudate. Two patients with Reiter's syndrome had the classical triad of symptoms (arthritis and conjunctivitis following nonspecific urethritis), and recovered from the episode uneventfully in 3 to 6 months. The one patient with ulcerative colitis had associated spondylitis with obliteration of the sacroiliac joints radiographically and recurring synovitis of the knees.
Only patients who had knee joints with effusions in excess of 15 ml. in volume were studied. The clinical estimation of the volume of effusion was usually checked at the end of an experiment by complete aspiration of the joint. Direct estimate of granulocyte lifespan by injection of labeled DFP into synovial effusions.
Initially, DFPa was used in the studies, but later the tritium-labeled compound was used because of its long radioactive half-life. Approximately 30 Uc of DFP8" (in 1 ml. volumes) or 30-100 ,uc of DFP-H8 (in 0.03 to 0.1 ml. of propylene glycol) were injected into the synovial exudate. To insure mixing, fluid was flushed back and forth in the syringe several times, and after the isotope injection the patient was asked to extend and flex his knee repeatedly. One hour was usually allowed for binding of DFP to cellular and exudate proteins, and samples of 1 to 3 ml. volume were withdrawn from the knee at intervals thereafter. After initial trials with varied time intervals, a suitable sequence was found to be 1, 2, 4, 6 and 8 hours after injection. The leukocytes were washed four times in saline and freed from any contaminating erythrocytes incident to the puncture by lysing the latter with hypotonic saline. The last wash contained only a trace of radioactivity. For the experiments with DFP', the leukocytes were suspended in absolute ethanol, transferred to stainless steel planchettes, and allowed to evaporate to dryness at room temperature. Radioactivity was then measured with a Nuclear Chicago windowless gas-flow counter, and corrections applied for radioactive decay. After the counting procedure was complete, the residues in the planchettes were dissolved in sodium hydroxide solution (1 N) and the nitrogen content estimated by the Kjeldahl and biuret methods. In studies with DFP-H', saline-washed labeled leukocytes were washed with cold perchloric acid (0.5M) to remove any small amounts of acid-soluble, presumably unbound, DFP, and the residue suspended in 0.2 N sodium hydroxide solution. Aliquots of the suspension were counted in a Packard Tri-Carb Spectrometer with a toluene-ethanol scintillation fluid containing p-bis (s-5-phenyloxazolyl)-benzene and 2,5-diphenyloxazole.' The radioactivity derived from DFP-H8 was expressed on the basis of the total number of leukocytes determined with a Coulter Model A particle counter. Radioactivity in the cell-free synovial exudate was also measured in some experiments.
RESULTS
Effect of the multiple aspirations on the cellular composition of synovial exudates
It was impossible to measure volume except by estimation, but none of the patients exhibited any clinically detectable change during the 8-hour period of most of the studies. Cell counts were obtained on almost all of the samples in nine patients ( Table 2 ). The first three patients in the Table are those with rheumatoid arthritis, and their counts were quite constant. One patient with Reiter's syndrome (G.D.) had a low initial cell count that seemed to fall with time. Two of the patients with acute gout (F.S. and N.B.) had surprisingly constant values, but the counts of one (M.K.) varied unpredictably and her initial low count suggests a laboratory error. Differential leukocyte counts were obtained in many of these patients, and showed no significant alterations during the course of the experiments.
Comparison of in vivo and in vitro labeling in one patient.
One patient was studied on three separate occasions. In one experiment (#1 in patient A.K. in Table 3 ) 44 ml. of joint fluid was withdrawn into a siliconized syringe containing 30 pc of DFP32 and incubated in vitro for 30 minutes before the exudate was returned to the synovial cavity.
In this experiment, blood leukocyte samples were assayed for p32 at the same times as the joint fluid, and only a trace of cell-associated radioactivity was detected.* The disappearance rate from this in vitro incubation experiment in this patient was similar to values obtained in two later experiments in which the DFP was directly injected into the synovial cavity ( Table 3 ). 
Loss of DFP-label from synovial exudate cells
In the 12 studies in patients with rheumatoid arthritis, 12 points were obtained 3 hours after the isotope injection; 10 points at 5 hours; * From a calculation of the total circulating granulocyte pool, the largest amount of total blood leukocyte radioactivity (detected 30 minutes after the return of the synovial fluid-DFP mixture to the joint cavity) represented only 3% of the cellassociated DFP in the joint fluid. This slight blood cell activity probably represented DFP not bound to protein or cells in the synovial fluid, but free to diffuse into the circulation and attach to blood leukocytes. However, a small migration of cells back from the synovial cavity into the blood cannot be excluded. In any event, the amount of cell-associated label in blood leukocytes was so low that migration of tagged cells from blood to synovial exudate would not have added detectably to the joint fluid cell-associated radioactivity. and 9 points at 7 hours. The mean values, with standard deviations, are shown in Figure 1 . In the effusions of patients with rheumatoid arthritis, therefore, the granulocyte half-life seems about 4 hours. Although Figure  1 is plotted on an arithmetic scale on which the curvilinear disappearance suggests a random destructive process, the actual data are too variable to permit any statistical evaluation of the mechanism of destruction (random destruction or finite lifespan). Although some of the patients had high titers of rheumatoid factor in their serum and marked morphological changes of vacuolization and degranulation in their synovial granulocytes, there was no gross difference in loss of cell-associated labeled DFP between those patients and the ones with negative rheumatoid factor tests and more normal granulocyte morphology. The two patients, A.K. and I.R., in whom more than one determination was available, are good examples. Both had chronic knee effusions present regularly for years and had similar rates of loss of cell label, 294 
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Similarly, of the three patients with overt gout and crystal phagocytosis only one (M.K.) seemed to have a somewhat rapid disappearance of cell-bound radioactivity in the effusion. The two patients with Reiter's disease (G.D. and J. deL.) also had loss of label from the cells in their synovial exudates similar to that of the patients with rheumatoid arthritis ( Table 3) . DISCUSSION To define further the rapidity of granulocyte destruction in rheumatoid effusions and to compare rheumatoid disease with other more acute synovial effusions, a method was needed for direct labeling of cells within the synovial cavity. Diisopropylfluorophosphate (DFP), labeled with either phosphorus32 or tritium, has been used to follow disappearance of granulocytes in the blood. Data of blood granulocyte half-life, obtained in this way, agree quite well with estimates obtained from granulokinetic data derived by other methods.' Since synovial exudate is free of erythrocytes and platelets, it seemed reasonable that DFP injected directly into the joint cavity would bind to granulocytes in the effusions. DFP does bind to mononuclear cells in blood,5 but the synovial effusions are so predominantly polymorphonuclear that the errors introduced by labeling of other exudate cells are small.
There are several potential inadequacies in using this method to label cells in synovial effusions: 1) continuing attachment of DFP to cells over a period longer than the arbitrary one hour used in most of these studies; 2) re-utilization of the label; 3) loss of fragile cells during the repeated saline washes, a phenomenon that definitely occurs in rheumatoid fluid6; 4) inadequate mixing in the total effusion when the label is injected into the suprapatellar synovial extension only; and 5) labeling of mononuclear phagocytes. Undoubtedly much of the variability noted from point to point in the patients (Table 3 ) result from such problems as variable loss of cells during washing and inadequate in vivo mixing.
The inherent and uncontrollable aspects of the method-incomplete fixation of the label, re-utilization, tagging of mononuclear cells-all tend to give more prolonged values for cell-associated labels. Only if loose binding of the isotope occurred, a problem not encountered in the many studies of blood leukocyte disappearance time,5'7 could the values obtained in these experiments be shortened spuriously. Therefore, it would seem that these observations are a conservative estimate of true survival time of granulocytes in these effusions.
These observations in patients with diverse synovial inflammatory disease, then, probably indicate a rapid destruction of exudate granulocytes in synovial effusions, regardless of the inflammatory stimulus. The halflife of exudative granulocytes is only a few hours, with only a small proportion of the original cells remaining after 24 hours. In chronic effusions, therefore, there is a large daily destruction of cells and their replacement from the blood, a turnover at least as great as the total granulocytes in the effusions. In a quite average 30 ml. rheumatoid effusion containing 25,000 granulocytes/cu.mm., the daily breakdown in the synovial cavity might well exceed a billion cells.
SUMMARY
The lifespan of granulocytes in inflammatory synovial effusions has been estimated by labeling cells with diisopropylfluorophosphate (DFP). Twelve studies in nine patients with rheumatoid arthritis and six studies in patients with other inflammatory joint disease were performed. The half-life of the granulocytes was about four hours in the rheumatoid patients, and the disappearance rate was similar in the other types of inflammatory synovitis.
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